K. Mulligan

发表

Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.

M. Schambelan, S. Noworolski, Madhu N. Rao, 2015, The Journal of clinical endocrinology and metabolism.

The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.

M. Schambelan, C. Grunfeld, J. Schwarz, 2009, The Journal of clinical endocrinology and metabolism.

Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers

M. Schambelan, Madhu N. Rao, C. Grunfeld, 2007, AIDS.

Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers.

M. Schambelan, C. Grunfeld, J. Schwarz, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study.

M. Schambelan, M. Noor, C. Grunfeld, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting--a clinical research center study.

M. Schambelan, V. Tai, K. Mulligan, 1998, The Journal of clinical endocrinology and metabolism.

Effects of Recombinant Human Growth Hormone on Body Composition and Metabolism in HIV-Associated Wasting

M. Schambelan, C. Grunfeld, M. Hellerstein, 1995 .

Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection.

M. Schambelan, C. Grunfeld, M. Hellerstein, 1993, The Journal of clinical endocrinology and metabolism.

Self management interventions for type 2 diabetes in adult people with severe mental illness.

K. Mulligan, C. Flood, A. Simpson, 2016, The Cochrane database of systematic reviews.

Self-management interventions for chronic illness

S. Newman, K. Mulligan, L. Steed, 2004, The Lancet.

The Official Positions of the International Society for Clinical Densitometry: body composition analysis reporting.

J. Shepherd, R. Fielding, K. Mulligan, 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Oral Glucose Tolerance and Insulin Sensitivity Are Unaffected by HIV Infection or Antiretroviral Therapy in Overweight Women

K. Anastos, J. Justman, N. Hessol, 2005, Journal of acquired immune deficiency syndromes.

Cardiovascular disease: the effect of erectile dysfunction on adherence to cardiovascular disease medication

K. Mulligan, H. McBain, P. Williams, 2014 .

Body shape changes in HIV-infected patients.

M. Schambelan, V. Tai, K. Mulligan, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation.

M. Schambelan, M. Noor, C. Grunfeld, 2002, The Journal of clinical endocrinology and metabolism.

Application and Effectiveness of Telehealth to Support Severe Mental Illness Management: Systematic Review

K. Mulligan, H. McBain, S. Lawes-Wickwar, 2018, JMIR mental health.

Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides

R. Shafer, R. Parker, G. Robbins, 2005, AIDS.

Nutritional recommendations for the management of sarcopenia.

L. Ferrucci, P. Ponikowski, D. Cella, 2010, Journal of the American Medical Directors Association.

The Association of Fat and Lean Tissue With Whole Body and Spine Bone Mineral Density Is Modified by HIV Status and Sex in Children and Youth

B. Coull, J. Lindsey, G. Aldrovandi, 2017, The Pediatric infectious disease journal.

The Wasting Report : Current Issues in Research and Treatment of HIV-Associated Wasting and Malnutrition

M. Schambelan, K. Mulligan, D. Kotler, 2012 .

Weight loss and wasting in patients infected with human immunodeficiency virus.

S. Grinspoon, K. Mulligan, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting.

M. Schambelan, K. Mulligan, 2002, International journal of cardiology.

Growth hormone receptor antagonism with pegvisomant in insulin resistant non-diabetic men: A phase II pilot study

M. Schambelan, E. Murphy, K. Mulligan, 2017, F1000Research.

Changes in Postprandial Glucose and Pancreatic Hormones , and Steady-State Insulin and Free Fatty Acids after Gastric Bypass Surgery

M. Schambelan, G. Campos, J. Schwarz, 2014 .

Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery.

M. Schambelan, Madhu N. Rao, G. Campos, 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers

M. Schambelan, C. Grunfeld, J. Schwarz, 2010, AIDS.

Boosting Dose Ritonavir Does Not Alter Peripheral Insulin Sensitivity in Healthy HIV-Seronegative Volunteers

M. Schambelan, C. Grunfeld, J. Schwarz, 2010, Journal of acquired immune deficiency syndromes.

The metabolic effects of lopinavir/ritonavir in HIV-negative men

M. Schambelan, M. Noor, C. Grunfeld, 2004, AIDS.

Metabolic effects of indinavir in healthy HIV-seronegative men

M. Schambelan, M. Noor, C. Grunfeld, 2001, AIDS.

Physical activity levels in patients on hemodialysis and healthy sedentary controls.

J. Kent‐Braun, K. Johansen, A. Ng, 2000, Kidney international.

Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.

M. Schambelan, Madhu N. Rao, C. Grunfeld, 2010, The Journal of clinical endocrinology and metabolism.

Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone

M. Schambelan, R. Grant, J. McCune, 2002, AIDS.

Using Cluster Heat Maps to Investigate Relationships Between Body Composition and Laboratory Measurements in HIV-Infected and HIV-Uninfected Children and Young Adults

J. Lindsey, G. Aldrovandi, E. Houseman, 2012, Journal of acquired immune deficiency syndromes.

Coronary heart disease: heart failure

A. Baum, K. Wallston, S. Ayers, 2001 .

Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein

K. Mulligan, C. Stephensen, B. Rutledge, 2013, Front. Genet..

Implementation of recommended type 2 diabetes care for people with severe mental illness – a qualitative exploration with healthcare professionals

K. Mulligan, C. Flood, A. Simpson, 2016, BMC Psychiatry.

Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome.

S. Noworolski, A. Gugliucci, R. Caccavello, 2016, Atherosclerosis.

Effects of Isocaloric Fructose Restriction on Ceramide Levels in Children with Obesity and Cardiometabolic Risk: Relation to Hepatic De Novo Lipogenesis and Insulin Sensitivity

S. Noworolski, J. Schwarz, K. Mulligan, 2022, Nutrients.

A Systematic Review of Self-Management Interventions for Children and Adolescents With Inflammatory Bowel Disease.

K. Mulligan, Lien Tran, 2018, Inflammatory bowel diseases.

Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.

J. Meigs, S. Haffner, H. Masur, 2008, Circulation.

Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.

M. Van Loan, K. Mulligan, C. Stephensen, 2012, The Journal of clinical endocrinology and metabolism.

Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?

C. Gordon, M. Van Loan, K. Mulligan, 2013, Antimicrobial Agents and Chemotherapy.

Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.

M. Van Loan, K. Mulligan, C. Stephensen, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Exploration of the Effect of Tobacco Smoking on Metabolic Measures in Young People Living with HIV

D. Harris, G. Aldrovandi, Mark L Rubinstein, 2014, AIDS research and treatment.

The Effects of a Web-Based Tool for Parents of Children With Juvenile Idiopathic Arthritis: Randomized Controlled Trial

L. Wedderburn, S. Newman, K. Mulligan, 2022, Journal of medical Internet research.

Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial.

K. Yarasheski, A. Zolopa, S. Koletar, 2008, The American journal of clinical nutrition.

Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

M. Schambelan, K. Feingold, C. Grunfeld, 1999, Metabolism: clinical and experimental.

Fat Distribution in HIV-Infected Women in the United States: DEXA Substudy in the Women's Interagency HIV Study

K. Anastos, J. Justman, N. Hessol, 2005, Journal of acquired immune deficiency syndromes.

Self management for men with lower urinary tract symptoms: randomised controlled trial

M. Emberton, D. Cromwell, S. Newman, 2006, BMJ : British Medical Journal.

A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy

H. Wand, W. Rozenbaum, D. Costagliola, 2010, HIV clinical trials.

Men’s beliefs about treatment for erectile dysfunction—what influences treatment use? A systematic review

P. Williams, A. Amirova, S. Newman, 2020, International Journal of Impotence Research.

Separation of postprandial lipoproteins: improved purification of chylomicrons using an ApoB100 immunoaffinity method

C. Pullinger, J. Kane, A. Gugliucci, 2019, Journal of Lipid Research.

Conversion of Sugar to Fat: Is Hepatic de Novo Lipogenesis Leading to Metabolic Syndrome and Associated Chronic Diseases?

J. Schwarz, K. Mulligan, M. Clearfield, 2017, The Journal of the American Osteopathic Association.

Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity.

S. Noworolski, A. Gugliucci, J. Schwarz, 2017, Gastroenterology.

Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome

S. Noworolski, A. Gugliucci, J. Schwarz, 2016, Obesity.

Metabolic Abnormalities in Patients with HIV Infection

K. Mulligan, 2003, Journal of the International Association of Physicians in AIDS Care.

Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting--a clinical research center study.

M. Schambelan, V. Tai, K. Mulligan, 1998, The Journal of clinical endocrinology and metabolism.

Body Composition in HIV Lipodystrophy

K. Mulligan, H. Khatami, 2003 .

Cross-sectional and longitudinal evaluation of body composition in men with HIV infection.

M. Schambelan, V. Tai, K. Mulligan, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting?

M. Schambelan, K. Mulligan, Giorgos K. Sakkas, 2009, Current opinion in clinical nutrition and metabolic care.

Disease Risk Factors Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular

J. Meigs, H. Masur, P. Reiss, 2008 .

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio

R. Parker, R. Fielding, S. Koletar, 2007, AIDS.

Dietary carbohydrates and fatty liver disease: de novo lipogenesis

J. Schwarz, K. Mulligan, S. Chiu, 2018, Current opinion in clinical nutrition and metabolic care.

Indinavir increases glucose production in healthy HIV-negative men

M. Schambelan, M. Noor, C. Grunfeld, 2004, AIDS.

Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.

J. V. Von Roenn, M. Schambelan, M. Chesney, 2007, The Journal of clinical endocrinology and metabolism.

HIV protease inhibitors increase adiponectin levels in HIV-negative men.

M. Schambelan, M. Noor, C. Grunfeld, 2004, Journal of acquired immune deficiency syndromes.

Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study

J. Kent‐Braun, M. Schambelan, K. Mulligan, 2009, PloS one.

Metabolic and Morphologic Complications in HIV Disease : What ’ s New ?

K. Mulligan, 2022 .

Altered Fat Distribution in HIV‐Positive Men on Nucleoside Analog Reverse Transcriptase Inhibitor Therapy

M. Schambelan, V. Tai, K. Mulligan, 2001, Journal of acquired immune deficiency syndromes.

Altered fat distribution in hiv-positive men on nucleoside analog reverse transcriptase inhibitor therapy

M. Schambelan, V. Tai, K. Mulligan, 2001 .

Thermogenic changes after gastric bypass, adjustable gastric banding or diet alone.

Madhu N. Rao, G. Campos, J. Schwarz, 2014, Surgery.

Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men

M. Schambelan, Madhu N. Rao, V. Tai, 2012, AIDS research and treatment.

in is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle.

U. Masharani, J. Youngren, I. Goldfine, 2011 .

Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis.

C. Gordon, K. Mulligan, S. Hosek, 2019, AIDS research and human retroviruses.

Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone

C. Gordon, K. Mulligan, C. Stephensen, 2018, Antiviral therapy.

Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial

Miguel Ángel Martínez, D. Harris, C. Gordon, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mapping the current psychology provision for children and young people with juvenile dermatomyositis

L. Wedderburn, F. Gibson, K. Mulligan, 2021, Rheumatology advances in practice.

OP-RAPC210062 1..8

L. Wedderburn, F. Gibson, K. Mulligan, 2021 .

Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children With Obesity and Metabolic Syndrome.

S. Noworolski, A. Gugliucci, R. Caccavello, 2019, The Journal of clinical endocrinology and metabolism.

Long-Term Body Fat Outcomes in Antiretroviral-Naive Participants Randomized to Nelfinavir or Efavirenz or Both Plus Dual Nucleosides: Dual X-Ray Absorptiometry Results From A5005s, a Substudy of Adult Clinical Trials Group 384

R. Parker, G. Robbins, R. Roubenoff, 2007, Journal of acquired immune deficiency syndromes.

Thalidomide for the treatment of AIDS-associated wasting.

M. Schambelan, P. Haslett, G. Kaplan, 2000, AIDS research and human retroviruses.

The effect of exercise on fructose absorption.

N. Kretchmer, J. Riby, K. Mulligan, 1993, The American journal of clinical nutrition.

The Acute Effects of HIV Protease Inhibitors on Insulin Suppression of Glucose Production in Healthy HIV-Negative Men

M. Schambelan, C. Grunfeld, J. Schwarz, 2009, Journal of acquired immune deficiency syndromes.

Effect of Vitamin D Supplementation on Bone Turnover Markers During HIV Pre-Exposure Prophylaxis Using Tenofovir Disoproxil Fumarate-Emtricitabine in Men Who Have Sex with Men.

Xiaoying Sun, Sonia Jain, K. Mulligan, 2019, AIDS research and human retroviruses.

Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate among transgender adolescents and young adults without HIV receiving gender affirming hormones.

K. Mulligan, M. Malhotra, S. Hosek, 2022, AIDS research and human retroviruses.

Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis

C. Gordon, M. Van Loan, K. Mulligan, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco

L. Grohskopf, E. Vittinghoff, S. Buchbinder, 2011, PloS one.

Strategies for the prevention and management of methotrexate-related nausea and vomiting in juvenile idiopathic arthritis: results of a UK Paediatric Rheumatology prescriber survey.

L. Wedderburn, V. Leone, K. Mulligan, 2015, Rheumatology.

Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021.

G. Aldrovandi, K. Mulligan, Fan Li, 2016, Journal of acquired immune deficiency syndromes.

Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.

D. Harris, G. Aldrovandi, R. Fielding, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Growth Hormone in AIDS

M. Schambelan, K. Mulligan, 2000 .

Use of growth hormone and other anabolic agents in AIDS wasting.

M. Schambelan, V. Tai, K. Mulligan, 1999, JPEN. Journal of parenteral and enteral nutrition.

Erectile dysfunction and its detection in the healthcare setting: 10 years on

K. Mulligan, H. McBain, P. Williams, 2015, International journal of clinical practice.

Cutis Verticis Gyrata in Men Affected by HIV-Related Lipodystrophy

T. Maurer, M. Schambelan, K. Mulligan, 2013, Dermatology research and practice.

Effects of recombinant human growth hormone on fat distribution in patients with human immunodeficiency virus-associated wasting.

M. Schambelan, V. Tai, K. Mulligan, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vitamin D3 Supplementation Increases Fibroblast Growth Factor-23 in HIV-Infected Youths Treated with Tenofovir Disoproxil Fumarate

C. Gordon, M. Van Loan, K. Mulligan, 2014, Antiviral therapy.

Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States

D. Harris, K. Mayer, G. Zimet, 2017, JAMA pediatrics.

Energy expenditure and protein metabolism in human immunodeficiency virus infection and cancer cachexia.

K. Mulligan, A. Bloch, 1998, Seminars in oncology.

Executive summary--nutritional care of HIV-infected adolescents and adults, including pregnant and lactating women: what do we know, what can we do, and where do we go from here?

K. Mulligan, D. Raiten, P. Papathakis, 2011, The American journal of clinical nutrition.

“Buffalo hump” in men with HIV-1 infection

Morris Schambelan, M. Schambelan, V. Tai, 1998, The Lancet.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

David V Glidden, Kenneth H Mayer, Mauro Schechter, 2010, The New England journal of medicine.

Enhanced Uridine Bioavailability Following Administration of a Triacetyluridine-Rich Nutritional Supplement

M. Schambelan, P. Jacob, U. Walker, 2011, PloS one.

HIV Infection and Diabetes

M. Schambelan, Madhu N. Rao, K. Mulligan, 2010 .

Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.

Jeannie S. Huang, C. Fichtenbaum, S. Swindells, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The effect of long-term storage on measured plasma lactate concentrations and prospective lactate results from a multicenter trial of antiretroviral therapy

R. Parker, D. Kitch, K. Mulligan, 2005, Clinical chemistry and laboratory medicine.

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis

D. Glidden, R. Grant, L. Bekker, 2014, AIDS.

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial.

D. Glidden, S. Buchbinder, R. Grant, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045

C. Gordon, J. Lindsey, G. Aldrovandi, 2010, AIDS.

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth

J. Lindsey, G. Aldrovandi, D. Jacobson, 2009, AIDS.

Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV‐1 Infection: Recommendations of an International AIDS Society‐USA Panel

M. Schambelan, M. Saag, J. Currier, 2002, Journal of acquired immune deficiency syndromes.

Changes in Bone Mass After Discontinuation of Pre-Exposure Prophylaxis (PrEP) with Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.

S. Perumean-Chaney, K. Mulligan, S. Hosek, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Measurement of de novo hepatic lipogenesis in humans using stable isotopes.

M. Hellerstein, C. Shackleton, K. Mulligan, 1991, The Journal of clinical investigation.

Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.

R. Parker, G. Robbins, R. Roubenoff, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Genetic analysis implicates resistin in HIV lipodystrophy

O. Flint, M. Noor, P. Tebas, 2008, AIDS.

Energy expenditure in human immunodeficiency virus infection.

M. Schambelan, V. Tai, K. Mulligan, 1997, The New England journal of medicine.

Psychometric analysis of the adult sickle cell quality of life measurement information system (ACSQ-Me) in a UK population

K. Mulligan, H. McBain, A. Yardumian, 2019, Health and Quality of Life Outcomes.

The psychology of rheumatic diseases.

S. Newman, K. Mulligan, 2000, Bailliere's best practice & research. Clinical rheumatology.

Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.

D. Harris, S. Stoszek, G. Aldrovandi, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled study

M. Schambelan, M. Noor, C. Grunfeld, 2002, AIDS.

A Critical Review of Self‐Management and Educational Interventions in Inflammatory Bowel Disease

S. Newman, K. Mulligan, D. Cooke, 2010, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection.

M. Schambelan, C. Grunfeld, D. Chernoff, 2000 .

Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection

M. Schambelan, C. Grunfeld, D. Chernoff, 2000, Journal of acquired immune deficiency syndromes.

Factors associated with weight loss after gastric bypass.

E. Vittinghoff, S. Rogers, A. Posselt, 2008, Archives of surgery.

Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.

M. Schambelan, K. Johansen, K. Mulligan, 1999, JAMA.

Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection

N. Benowitz, M. Schambelan, T. Elbeik, 2003, Annals of Internal Medicine.

The Official Positions of the International Society for Clinical Densitometry: Indications of Use and Reporting of DXA for Body Composition.

J. Shepherd, R. Fielding, D. Krueger, 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting

A. LaMarca, Jack Wang, M. Schambelan, 1996, Annals of Internal Medicine.

Psychoeducational interventions in rheumatic diseases: A review of papers published from September 2001 to August 2002

S. Newman, K. Mulligan, 2003, Current opinion in rheumatology.

The design and evaluation of a self-management intervention for patients admitted to hospital with heart failure

K. Mulligan, 2008 .

The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.

M. Schambelan, R. Halvorsen, M. Noor, 2001, The Journal of clinical endocrinology and metabolism.

Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine

D. Glidden, S. Buchbinder, R. Grant, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM

K. Mayer, G. Zimet, K. Mulligan, 2017, Journal of acquired immune deficiency syndromes.

Cognitive change 5 years after coronary artery bypass surgery.

S. Newman, K. Mulligan, L. Steed, 2003, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis

D. Glidden, S. Buchbinder, R. Grant, 2017, Journal of acquired immune deficiency syndromes.

Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.

G. Robbins, D. Haas, T. Hulgan, 2008, The Journal of infectious diseases.

Leptin, body composition, and indices of malnutrition in patients on dialysis.

M. Schambelan, K. Johansen, V. Tai, 1998, Journal of the American Society of Nephrology : JASN.

The effect of heart failure nurse consultations on heart failure patients' illness beliefs, mood and quality of life over a six-month period.

W. Banya, M. Cowie, S. Newman, 2015, Journal of clinical nursing.

Newly diagnosed heart failure: change in quality of life, mood, and illness beliefs in the first 6 months after diagnosis.

M. Cowie, T. McDonagh, S. Newman, 2012, British journal of health psychology.

Are diabetes self-management programmes for the general diabetes population effective for people with severe mental illness?: a systematic review

K. Mulligan, A. Coxon, H. McBain, 2020, BMC Psychiatry.

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

A. LaMarca, J. Wang, M. Schambelan, 1996, Annals of internal medicine.

Psychosocial interventions for caregivers of people with dementia: a systematic review.

S. Newman, K. Mulligan, L. McNally, 2001, Aging & mental health.

Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.

J. Currier, K. Mulligan, R. Clark, 2005, Archives of internal medicine.

Changes in weight and lean body mass during highly active antiretroviral therapy.

C. Shikuma, K. Mulligan, D. Mildvan, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

303 Improved Outcomes Following Hospitalisation In Patients With A New Diagnosis Of Heart Failure: Results From A Randomised Controlled Trial Of A Novel, Nurse-led Self-management Intervention

M. Cowie, S. Newman, S. Hardman, 2006 .

Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T.

Xiaojuan Li, S. Majumdar, M. Schambelan, 2008, Magnetic resonance imaging.

Mixed Patterns of Changes in Central and Peripheral Fat Following Initiation of Antiretroviral Therapy in a Randomized Trial

R. Parker, G. Robbins, R. Roubenoff, 2006, Journal of acquired immune deficiency syndromes.

Management of type 2 diabetes mellitus in people with severe mental illness: an online cross-sectional survey of healthcare professionals

K. Mulligan, C. Flood, A. Simpson, 2018, BMJ Open.

Improvement in Peripheral Glucose Uptake After Gastric Bypass Surgery Is Observed Only After Substantial Weight Loss Has Occurred and Correlates with the Magnitude of Weight Lost

M. Schambelan, Madhu N. Rao, G. Campos, 2009, Journal of Gastrointestinal Surgery.

The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection.

Jeffrey N. Martin, M. Schambelan, S. Deeks, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The design and evaluation of psychoeducational/self-management interventions.

Erik Taal, E. Taal, J. Rasker, 2005, The Journal of rheumatology.

What is meant by self-management and how can its efficacy be established?

S. Newman, K. Mulligan, L. Steed, 2001, Rheumatology.

Being on the juvenile dermatomyositis rollercoaster: a qualitative study

J. Stinson, L. Wedderburn, F. Gibson, 2019, Pediatric Rheumatology.

Psychosocial interventions for caregivers of people with dementia: a systematic review

K. Mulligan, L. McNally, D. Cooke, 2001 .

The association of bone mineral density with HIV infection and antiretroviral treatment in women

Mardge H. Cohen, K. Anastos, J. Justman, 2007, Antiviral therapy.

Barriers to effective diabetes management – a survey of people with severe mental illness

K. Mulligan, C. Flood, A. Simpson, 2018, BMC Psychiatry.

Subchronic sleep restriction causes tissue-specific insulin resistance.

M. Schambelan, Madhu N. Rao, T. Neylan, 2015, The Journal of clinical endocrinology and metabolism.

Self-management interventions

K. Mulligan, 2019 .

Discrepancies between energy intake and expenditure in physically active women

K. Mulligan, G. Butterfield, 1990, British Journal of Nutrition.

Severe mental illness and type 2 diabetes: using theory and research evidence to develop complex behaviour change interventions.

K. Mulligan, C. Flood, A. Simpson, 2016, Journal of psychiatric and mental health nursing.

Prevalence and Predictors of Metabolic Syndrome Among HIV-Infected and HIV-Uninfected Women in the Women's Interagency HIV Study

S. Cole, Mardge H. Cohen, K. Anastos, 2008, Journal of acquired immune deficiency syndromes.

Do mothers and fathers hold similar views about their child's arthritis?

L. Wedderburn, S. Newman, K. Mulligan, 2009, Arthritis and rheumatism.

Changes in Lean Mass, Absolute and Relative Muscle Strength, and Physical Performance After Gastric Bypass Surgery

P. Cawthon, J. Carter, L. Stewart, 2019, The Journal of clinical endocrinology and metabolism.

Clinical trials update in human immunodeficiency virus wasting.

K. Mulligan, N. Muurahainen, 1998, Seminars in oncology.

Development of research nutrient data bases: An example using foods consumed in rural Kenya

D. Calloway, K. Mulligan, S. Murphy, 1991 .

Insulin Resistance in Non-Obese Subjects Is Associated with Activation of the JNK Pathway and Impaired Insulin Signaling in Skeletal Muscle

Xiaojuan Li, M. Schambelan, U. Masharani, 2011, PloS one.

Dual-energy X-ray absorptiometry-based body volume measurement for 4-compartment body composition.

Bo Fan, John A Shepherd, J. Shepherd, 2012, The American journal of clinical nutrition.

Dual-energy X-ray absorptiometry – based body volume measurement for 4-compartment body composition 1 – 3

J. Shepherd, K. Mulligan, B. Fan, 2011 .

Diabetes self-management in people with severe mental illness

K. Mulligan, C. Flood, A. Simpson, 2014 .

Using the behaviour change wheel and person-based approach to develop a digital self-management intervention for patients with adrenal insufficiency: the Support AI study protocol

K. Mulligan, S. Hirani, C. Norton, 2023, Frontiers in Endocrinology.

Barriers and enablers of type 2 diabetes self‐management in people with severe mental illness

K. Mulligan, C. Flood, A. Simpson, 2017, Health expectations : an international journal of public participation in health care and health policy.

Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons.

Jeffrey N. Martin, S. Deeks, K. Mulligan, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chronic Physical Illness: Self-Management and Behavioural Interventions

Stanton Newman, Liz Steed, Kathleen Mulligan, 2008 .

Barriers and enablers to the implementation of evidence-based practice in pressure ulcer prevention and management in an integrated community care setting: A qualitative study informed by the theoretical domains framework.

K. Mulligan, C. McGraw, Carole Y. Taylor, 2021, Health & social care in the community.

Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life

L. Wedderburn, S. Newman, K. Mulligan, 2013, Pediatric Rheumatology.

Reply to Collazos et al

G. Robbins, R. Roubenoff, P. Tebas, 2007 .

Cost-Effectiveness of Herpes Zoster Vaccine : Flawed Assumptions Regarding Efficacy against Postherpetic Neuralgia

G. Robbins, R. Roubenoff, P. Tebas, 2010 .

Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials group studies.

K. Squires, K. Mulligan, C. Benson, 2001, The Journal of infectious diseases.

The prevalence of erectile dysfunction in men attending cardiac rehabilitation: an audit in East London

P. Williams, K. Mulligan, H. McBain, 2017 .

Abstract 16511: Isocaloric Fructose Restriction Improves Postprandial Chylomicron and VLDL Excursions in Adolescents With Obesity by Reducing Angiopoietin-Like Protein 3 and Apolipoprotein CIII

S. Noworolski, A. Gugliucci, R. Caccavello, 2020 .

The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people

L. Wedderburn, S. Newman, K. Mulligan, 2015, Pediatric Rheumatology.